← Back to Search

App for Monitoring Chemotherapy Side Effects in Breast Cancer

Research Sponsored by Julie Lemieux
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Screening 3 weeks
Treatment Varies
Follow Up 3 months
Awards & highlights

Study Summary

This trial is aimed at exploring the use of a web-based patient portal to improve the monitoring of oral therapy toxicities in breast cancer patients.

Who is the study for?
This trial is for adults over 18 with metastatic breast cancer who are currently taking oral chemotherapy drugs like palbociclib, everolimus, or capecitabine. Participants need to have a smartphone, tablet, or computer. Those with cognitive impairments cannot join.Check my eligibility
What is being tested?
The study is testing an app designed to help patients self-report side effects from oral chemotherapy treatments. The goal is to see if this can improve patient care and safety by providing systematic monitoring outside of the hospital setting.See study design
What are the potential side effects?
While not directly related to the app being tested, the oral chemotherapies involved may cause side effects such as nausea, fatigue, diarrhea, low blood cell counts leading to increased infection risk and other specific drug-related toxicities.


Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Number of calls

Trial Design

1Treatment groups
Experimental Treatment
Group I: ApplicationExperimental Treatment1 Intervention

Find a Location

Who is running the clinical trial?

Julie LemieuxLead Sponsor

Media Library

Application Clinical Trial Eligibility Overview. Trial Name: NCT05743686 — N/A
Breast Cancer Research Study Groups: Application
Breast Cancer Clinical Trial 2023: Application Highlights & Side Effects. Trial Name: NCT05743686 — N/A
Application 2023 Treatment Timeline for Medical Study. Trial Name: NCT05743686 — N/A
~12 spots leftby Jun 2025